Hakimi Rainer
HALLESCHE Krankenversicherung, Stuttgart.
Versicherungsmedizin. 2012 Jun 1;64(2):74-7.
The expert questioning of when a treatment with testosterone is medically necessary has increased by several 100% in the daily work of the insurance medical expert in the past years. The reason for this is that testosterone is prescribed a lot more often nowadays than it was 10 years ago. One can suspect that testosterone has become part of a popular lifestyle medication. However, the clinical meaning of the age-dependent decrease of testosterone in men is controversial. Unfortunately, there are only few study data about hypogonadism in ageing men. Testosterone treatment has a very narrow application field and is only medically necessary if the low testosterone level has been clinically proven as well as in a medical lab examination. This is decisive because testosterone treatment has numerous limitations of application and has a wide range of side effects. This article shows the controversy surrounding the discussion on testosterone treatment and the pitfalls of issuing the insurance medical expert's report.
在过去几年里，保险医学专家日常工作中对于睾酮治疗在医学上何时必要的专业质疑增加了数百%。原因在于如今睾酮的处方量比10年前要多得多。人们可以怀疑睾酮已成为流行的生活方式类药物的一部分。然而，男性体内睾酮随年龄下降的临床意义存在争议。不幸的是，关于老年男性性腺功能减退的研究数据很少。睾酮治疗的应用领域非常狭窄，只有在临床和医学实验室检查均证实睾酮水平低时才在医学上有必要使用。这一点很关键，因为睾酮治疗有诸多应用限制且副作用广泛。本文展示了围绕睾酮治疗讨论的争议以及出具保险医学专家报告时的陷阱。
